Brainstorm Cell Therapeutics, Inc. (BCLI)
1.065
-0.06
(-5.19%)
USD |
OTCM |
Aug 31, 16:00
Brainstorm Cell Therapeutics Cash from Operations (Annual) : -6.975M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -6.975M |
| December 31, 2024 | -9.093M |
| December 31, 2023 | -20.46M |
| December 31, 2022 | -19.32M |
| December 31, 2021 | -26.26M |
| December 31, 2020 | -35.19M |
| December 31, 2019 | -11.25M |
| December 31, 2018 | -12.39M |
| December 31, 2017 | -2.364M |
| December 31, 2016 | -5.858M |
| December 31, 2015 | -7.408M |
| December 31, 2014 | -4.487M |
| December 31, 2013 | -4.054M |
| Date | Value |
|---|---|
| December 31, 2012 | -2.916M |
| December 31, 2011 | -2.223M |
| December 31, 2010 | -2.069M |
| December 31, 2009 | -0.744M |
| December 31, 2008 | -1.734M |
| December 31, 2007 | -1.774M |
| December 31, 2006 | -0.8546M |
| March 31, 2006 | |
| March 31, 2005 | -0.6778M |
| March 31, 2004 | -0.0154M |
| March 31, 2003 | -0.007M |
| March 31, 2002 | -0.0074M |
| March 31, 2001 | -0.0065M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| NovelStem International Corp. | -0.1676M |
| Summit Therapeutics, Inc. | -322.93M |
| Kezar Life Sciences, Inc. | -51.78M |
| Protara Therapeutics, Inc. | -56.36M |
| Clene, Inc. | -18.55M |